Glucuronidation and the UDP-glucuronosyltransferases in health and disease

Drug Metabolism and Disposition

Volumn 32, Issue 3, 2004, Pages 281-290

  Wells, Peter G ^a   Mackenzie, Peter I ^b   Chowdhury, Jayanta Roy ^d   Guillemette, Chantal ^e   Gregory, Philip A ^b   Ishii, Yuji ^c   Hansen, Antony J ^b   Kessler, Fay K ^f   Kim, Perry M ^a   Chowdhury, Namita Roy ^d   Ritter, Joseph K ^f,g  

^a UNIVERSITY OF TORONTO   (Canada)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c KYUSHU UNIVERSITY   (Japan)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITÉ LAVAL   (Canada)

^f VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^g VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BENZO[A]PYRENE; BILIRUBIN; CYTOCHROME P450; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA; ESTRADIOL; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; ISOENZYME; NITROSAMINE; NUCLEAR FACTOR I; OLTIPRAZ; PARACETAMOL; PHENOBARBITAL; POLYCYCLIC AROMATIC HYDROCARBON; PROSTAGLANDIN SYNTHASE; TRANSCRIPTION FACTOR; VIRUS VECTOR; XENOBIOTIC AGENT;

ALLELE; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; CRIGLER NAJJAR SYNDROME; ENZYME DEFICIENCY; GENE; GENE CONTROL; GENE SEQUENCE; GENE STRUCTURE; GENE THERAPY; GENE TRANSFER; GENETIC POLYMORPHISM; GILBERT DISEASE; GLUCURONIDATION; HUMAN; LIVER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

ANIMALS; DISEASE; GENE THERAPY; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HEALTH; HUMANS; NEOPLASMS; PHARMACOGENETICS; RISK FACTORS; XENOBIOTICS;

EID: 10744227696     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.32.3.281     Document Type: Conference Paper

References (103)

1. Akaba K, Kimura T, Sasaki A, Tanabe S, Ikegami T, Hashimoto M, Umeda H, Yoshida H, Umetsu K, Chiba H, et al. (1998) Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese. Biochem Mol Biol Int 46:21-26.
2. Beaulieu M, Levesque E, Tchernof A, Beatty BG, Belanger A, and Hum DW (1997) Chromosomal localization, structure and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme. DNA Cell Biol 16:1143-1154.
3. Bernard P, Goudonnet H, Artur Y, Desvergne B, and Wahli W (1999) Activation of the mouse TATA-less and human TATA-containing UDP-glucuronosyltransferase 1A1 promoters by hepatocyte nuclear factor 1. Mol Pharmacol 56:526-536.
4. Beutler E, Gelbart T, and Demina A (1998) Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 95:8170-8174.
5. Bock KW, Forster A, Gschaidmeier H, Bruck M, Munzel P, Schareck W, Fournel-Gigleux S, and Burchell B (1993) Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases. Biochem Pharmacol 45:1809-1814.
6. Bosma PJ, Roy Chowdhury J, and Bakker C (1995) The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase I in Gilbert's syndrome. New Engl J Med 333: 1171-1175.
7. Bosma PJ, Seppen J, Goldhoorn B, Bakker C, Oude Elferink RP, Roy Chowdhury J, Roy Chowdhury N, and Jansen PL (1994) Bilirubin UDP-glucuronosyltransferase I is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 269:17960-17964.
8. Ciotti M, Marrone A, Potter C, and Owens IS (1997) Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics 7:485-495.
9. Coffman BL, King CD, Rios GR, and Tephly TR (1998) The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab Dispos 26:73-77.
10. Court MH, Duan SX, von Moltke LL, Greenblatt DJ, Patten CJ, Miners JO, and Mackenzie PI (2001) Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther 299:998-1006.
11. Davies MH and Schnell RC (1991) Oltipraz-induced amelioration of acetaminophen hepatotoxicity in hamsters. II. Competitive shunt in metabolism via glucuronidation. Toxicol Appl Pharmacol 109:29-40.
12. de Morais SMF, Chow SYM, and Wells PG (1992a) Biotransformation and toxicity of acetaminophen in congenic RHA rats with or without a hereditary deficiency in UDP-glucuronosyltransferase. Toxicol Appl Pharmacol 117:81-87.
13. de Morais SMF, Uetrecht JP, and Wells PG (1992b) Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome. Gastroenterology 102:577-586.
14. de Morais SMF and Wells PG (1988) Deficiency in bilirubin UDP-glucuronyl transferase as a genetic determinant of acetaminophen toxicity. J Pharmacol Exp Ther 247:323-331.
15. de Morais SMF and Wells PG (1989) Enhanced acetaminophen toxicity in rats with bilirubin UDP-glucuronyl transferase deficiency. Hepatology 10:163-167.
16. Ebner T, Remmel RP, and Burchell B (1993) Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol. Mol Pharmacol 43:649-654.
17. Esteban A and Perez-Mateo M (1999) Heterogeneity of paracetamol metabolism in Gilbert's syndrome. Eur J Drug Metab Pharmacokinet 24:9-13.
18. Fang JL, Beland FA, Doerge DR, Wiener D, Guillemette C, Marques MM, and Lazarus P (2002) Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes. Cancer Res 62:1978-1986.
19. Fox IJ, Roy Chowdhury J, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI, Dorko K, Sauter BV, and Strom SC (1998) Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338:1422-1426.
20. Gestl SA, Green MD, Shearer DA, Frauenhoffer E, Tephly TR, and J Weisz (2002) Expression of UGT2B7, a UDP-glucuronosyltransferase implicated in the metabolism of 4-hydroxyestrone and all-trans retinoic acid, in normal human breast parenchyma and in invasive and in situ breast cancers. Am J Pathol 160:1467-1479.
21. Girard H, Journault K, and Guillemette C (2003) Haplotypic structure of the carcinogen-metabolizing enzyme UGT1A7: nine polymorphic alleles (*1 through *9). Abstract 7485, in ASPET, Experimental Biology 2003, April 11-15, 2003, San Diego, CA.
22. Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, and Popescu NC (2001) Thirteen UDP glucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11:357-368.
23. Gregory PA, Hansen AJ, and Mackenzie PI (2000) Tissue specific differences in the regulation of the UDP glucuronosyltransferase 2B17 gene promoter. Pharmacogenetics 10:809-820.
24. Grove AD, Kessler FK, Metz RP, and Ritter JK (1997) Identification of a rat oltipraz-inducible UDP-glucuronosyltransferase (UGT1A7) with activity towards benzo(a)pyrene-7,8-dihydrodiol. J Biol Chem 272:1621-1627.
25. Grove AD, Llewellyn GC, Kessler FK, White KL, Crespi CL, and Ritter JK (2000) Differential protection by rat UDP-glucuronosyltransferase 1A7 against benzo[a]pyrene-3,6-quinone-versus benzo[a]pyrene-induced cytotoxic effects in human lymphoblastoid cells. Toxicol Appl Pharmacol 162:34-43.
26. Gsur A, Preyer M, Haidinger G, Schatzl G, Madersbacher S, Marberger M, Vutuc C, and Micksche M (2002) A polymorphism in the UDP-glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 11:497-498.
27. Guha C, Parashar B, Deb NJ, Garg M, Gorla GR, Singh A, Roy-Chowdhury N, Vikram B, and Roy-Chowdhury J (2002) Long-term normalization of serum bilirubin levels by massive repopulation of Gunn rat liver by normal hepatocytes, transplanted after preparative hepatic irradiation and partial hepatectomy. Hepatology 36:354-362.
28. Guha C, Sharma A, Gupta S, Alfieri A, Gorla GR, Gagandeep S, Sokhi R, Roy-Chowdhury N, Tanaka KE, Vikram B, and Roy-Chowdhury J (1999) Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res 59:5871-5874.
29. Guillemette C, De Vivo I, Hankinson SE, Haiman CA, Spiegelman D, Housman DE, and Hunter DJ (2001) Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels. Cancer Epidemiol Biomarkers Prev 10:711-714.
30. Guillemette C, Levesque E, Beaulieu M, Turgeon D, Hum DW, and Belanger A (1997) Differential regulation of two uridine diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells. Endocrinology 138:2998-3005.
31. Guillemette C, Millikan R, Newman B, and Housman DE (2000a) Genetic polymorphisms in UGT1A1 and association with breast cancer among African Americans. Cancer Res 60:950-956.
32. Guillemette C, Ritter JK, Auyeung DJ, Kessler FK, and Housman DE (2000b) Structural heterogeneity at the UDP-glucuronosyltransferase 1A locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 10:629-644.
33. Guillemette CG (2003) Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenom J 3:136-158.
34. Gupta S, Aragona E, Vemuru RP, Bhargava KK, Burk RD, and Chowdhury JR (1991) Permanent engraftment and function of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation. Hepatology 14:144-149.
35. Haiman CA, Hankinson SE, De Vivo I, Guillemette C, Ishibe N, Hunter DJ, and Byrne C (2003) Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat 77:27-36.
36. Hall D, Ybazeta G, Destro-Bisol G, Petzl-Erler ML, and Di Rienzo A (1999) Variability at the uridine diphosphate glucuronosyltransferase 1A1 promoter in human populations and primates. Pharmacogenetics 9:591-599.
37. Hansen AJ, Lee YH, Gonzalez FJ, and Mackenzie PI (1997) HNF1 alpha activates the rat UDP glucuronosyltransferase UGT2B1 gene promoter. DNA Cell Biol 16:207-214.
38. Hansen AJ, Lee YH, Sterneck E, Gonzalez FJ, and Mackenzie PI (1998) C/EBPalpha is a regulator of the UDP glucuronosyltransferase UGT2B1 gene. Mol Pharmacol 53:1027-1033.
39. Haque SJ, Petersen DD, Nebert DW, and Mackenzie PI (1991) Isolation, sequence and developmental expression of rat UGT2B2: the gene encoding a constitutive UDP glucuronosyltransferase that metabolizes etiocholanolone and androsterone. DNA Cell Biol 10:515-524.
40. Hu Z and Wells PG (1992) In vitro and in vivo biotransformation and covalent binding of benzo(a)pyrene in rats with a genetic deficiency in bilirubin UDP-glucuronosyltransferase. J Pharmacol Exp Ther 263:334-342.
41. Hu Z and Wells PG (1993) Human interindividual variation in lymphocyte UDP-glucuronosyltransferases as a determinant of benzo[a]pyrene covalent binding and cytotoxicity. ISSX Proc 4:241.
42. Hu Z and Wells PG (1994) Modulation of benzo[a]pyrene bioactivation and cytotoxicity by glucuronidation in lymphocytes and hepatic microsomes from rats with a hereditary deficiency in bilirubin UDP-glucuronosyltransferase. Toxicol Appl Pharmacol 127:306-313.
43. Huang YH, Galijatovic A, Nguyen N, Geske D, Beaton D, Green J, Green M, Peters WH, and Tukey RH (2002) Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3. Pharmacogenetics 12:287-297.
44. Ikushiro S, Emi Y, and Iyanagi T (1995) Identification and analysis of drug-responsive expression of UDP-glucuronosyltransferase family 1 (UGT1) isozyme in rat hepatic microsomes using anti-peptide antibodies. Arch Biochem Biophys 324:267-272.
45. Ilan Y, Attavar P, Takahashi M, Davidson A, Horwitz M, Guida J, Roy Chowdhury N, and Roy Chowdhury J (1996) Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats. J Clin Investig 98:2640-2647.
46. Ilan Y, Prakash R, Davidson A, Jona V, Droguett G, Horwitz MS, Roy Chowdhury N, and Roy Chowdhury J (1997) Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors. J Clin Investig 99:1098-1106.
47. Ishii Y, Hansen AJ, and Mackenzie PI (2000) Octamer transcription factor-1 enhances hepatic nuclear factor-1 alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter. Mol Pharmacol 57:940-947.
48. Iyanagi T, Emi Y, and Ikushiro S (1998) Biochemical and molecular aspects of genetic disorders of bilirubin metabolism. Biochim Biophys Acta 1407:173-174.
49. Iyer L, King CD, Whitington PF, Green MD, Roy SK, Tephly TR, Coffman BL, and Ratain MJ (1998) Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J Clin Investig 101:847-854.
50. Izsvák Z, Ivics Z, and Plasterk RH (2000) Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J Mol Biol 302:93-102.
51. Jinno H, Saeki M, Saito Y, Tanaka-Kagawa T, Hanioka N, Sai K, Kaniwa N, Ando M, Shirao K, Minami H, et al. (2003a) Functional characterization of human UDP-glucuronosyltransferase (UGT) 1A9 variant, D256N, found in Japanese cancer patients. J Pharmacol Exp Ther 306:688-693.
52. Jinno H, Saeki M, Tanaka-Kagawa T, Hanioka N, Saito Y, Ozawa S, Ando M, Shirao K, Minami H, Ohtsu A, et al. (2003b) Functional characterization of wild-type and variant (T202I and M59I) human UDP-glucuronosyltransferase 1A10. Drug Metab Dispos 31:528-532.
53. Kessler FK, Kessler MR, Auyeung DJ, and Ritter JK (2002) Glucuronidation of acetaminophen catalyzed by multiple rat phenol UDP-glucuronosyltransferases. Drug Metab Dispos 30:324-330.
54. Kessler FK and Ritter JK (1997) Induction of a rat liver benzo[a]pyrene-trans-7,8-dihydrodiol glucuronidating activity by oltipraz and beta-naphthoflavone. Carcinogenesis 18:107-114.
55. Kim PM, DeBoni U, and Wells PG (1997a) Peroxidase-dependent bioactivation and oxidation of DNA and protein in benzo[a]pyrene-initiated micronucleus formation. Free Radic Biol Med 23:579-596.
56. Kim PM and Wells PG (1996a) Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo[a]pyrene. Cancer Res 56: 1526-1532.
57. Kim PM and Wells PG (1996b) Phenytoin-initiated hydroxyl radical formation: characterization by enhanced salicylate hydroxylation. Mol Pharmacol 49:172-181.
58. Kim PM and Wells PG (1998) Phenytoin embryotoxicity: protection by UDP-glucuronosyltransferases. Toxicol Sci 42(1-S):261 (No. 1288).
59. Kim PM, Winn LM, Parman T, and Wells PG (1997b) UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin (HPPH). J Pharmacol Exp Ther 280:200-209.
60. Kobayashi T, Yokota H, Ohgiya S, Iwano H, and Yuasa A (1998) UDP-glucuronosyltransferase UGT1A7 induced in rat small intestinal mucosa by oral administration of 2-naphthoflavone. Eur J Biochem 258:948-955.
61. Kren B, Parashar B, Bandopadhyay P, Roy Chowdhury N, Roy Chowdhury J, and Steer CJ (1999) Correction of the UDP-glucuronosyltransferase gene defect in the Gunn rat model of Crigler-Najjar syndrome type I. Proc Natl Acad Sci USA 96:10349-10354.
62. Lampe JW, Bigler J, Bush AC, and Potter JD (2000). Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y). Cancer Epidemiol Biomarkers Prev 9:329-333.
63. Lampe JW, Bigler J, Horner NK, and Potter JD (1999) UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations. Pharmacogenetics 9:341-349.
64. Lee YH, Sauer B, Johnson PF, and Gonzalez FJ (1997) Disruption of the C/Ebp-alpha gene in adult mouse liver. Mol Cell Biol 17:6014-6022.
65. Levesque E, Beaulieu M, Green MD, Tephly TR, Belanger A, and Hum DW (1997) Isolation and characterization of UGT2B 15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7:317-325.
66. Levesque E, Beaulieu M, Hum DW, and Belanger A (1999) Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 9:207-216.
67. Levesque EE, Turgeon D, Carrier JS, Montminy V, Beaulieu M, and Belanger A (2001) Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronosyltransferase. Biochemistry 40:3869-3881.
68. Lichtsteiner S, Wuarin J, and Schibler U (1987) The interplay of DNA-binding proteins on the promoter of the mouse albumin gene. Cell 51:963-973.
69. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Bélanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, et al. (1997) The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255-269.
70. Mackenzie PI and Rodbourn L (1990) Organization of the rat UDP-glucuronosyltransferase, UDPGTr-2, gene and characterization of its promoter. J Biol Chem 265:11328-11332.
71. MacLeod SL, Nowell S, Plaxco J, and Lang NP (2000) An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer. Ann Surg Oncol 7:777-782.
72. Maruo Y, Nishizawa K, Sato H, Doida Y, and Shimada M (1999) Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics 103:1224-1227.
73. Mojarrabi B and Mackenzie PI (1998) Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon. Biochem Biophys Res Commun 247:704-709.
74. Monaghan G, Burchell B, and Boxer M (1997) Structure of the human Ugt2b4 gene encoding a bile acid UDP-glucuronosyltransferase. Mamm Genome 8:692-694.
75. Nakai H, Yant SR, Storm TA, Fuess S, Meuse L, and Kay MA (2001) Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J Virol 75:6969-6976.
76. Owens IS and Ritter JK (1992) The novel bilirubin/phenol UDP-glucuronosyltransferase UGT1 gene locus: implications for multiple nonhemolytic familial hyperbilirubinemia phenotypes. Pharmacogenetics 2:93-108.
77. Radominska-Pandya A, Czernik PJ, Little JM, Battaglia E, and Mackenzie PI (1999) Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 31:817-899.
78. Riedy M, Wang JY, Miller AP, Buckler A, Hall J, and Guida M (2000) Genomic organization of the UGT2b gene cluster on human chromosome 4q13. Pharmacogenetics 10:251-260.
79. Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, and Owens IS (1992) A novel complex locus UGT1 encodes human bilirubin, phenol and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem 267:3257-3261.
80. Ritter JK, Kessler FK, Thompson MT, Grove AD, Auyeung DJ, and Fisher RA (1999) Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences, Hepatology 30:476-484.
81. Roy Chowdhury J, Grossman M, Gupta S, Roy Chowdhury N, Baker JR Jr, and Wilson JM (1991) Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDL-receptor deficient rabbits. Science (Wash DC) 254:1802-1805.
82. Roy Chowdhury N, Hays RM, Bommineni VR, Franki N, Roy Chowdhury J, Wu CH, and Wu GY (1996) Microtubular distribution prolongs the expression of human bilirubin-uridinediphosphoglucuronate-glucuronosyltransferase-1 gene transferred into Gunn rat livers. J Biol Chem 271:2341-2346.
83. Roy Chowdhury J, Roy Chowdhury N, Strom SC, Kaufman SS, Horslen S, and Fox IJ (1998) Hepatocyte transplantation in humans: gene therapy and more. Pediatrics 102:647-648.
84. Roy Chowdhury J, Wolkoff AW, Roy Chowdhury N, and Arias IM (2001) Hereditary jaundice and disorders of bilirubin metabolism, in The Metabolic and Molecular Basis of Inherited Disease, 8th ed (Scriver CR, Boudet AL, Sly W, Valle D, Childs B, Kinzler K, and Vogelstein B, eds) pp 3063-3101, McGraw-Hill, New York.
85. Sauter BV, Parashar B, Roy Chowdhury N, Kadakol A, Ilan Y, Singh H, Milano J, Strayer DS, and Roy Chowdhury J (2000) Gene transfer to the liver using a replication-deficient recombinant SV40 vector results in long-term amelioration of jaundice in Gunn rats. Gastroenterology 119:1348-1357.
86. Senafi SB, Clarke DJ, and Burchell B (1994) Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J 303:233-240.
87. Strassburg CP, Nguyen N, Manns MP, and Tukey RH (1998) Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol Pharmacol 54:647-654.
88. Strassburg CP, Vogel A, Kneip S, Tukey RH, and Manns MP (2002) Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 50:851-856.
89. Strayer DS, Branco F, Zern MA, Yam P, Calarota SA, Nichols CN, Zaia JA, Rossi J, Li H, Parashar B, et al. (2002) Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors. Mol Ther 6:227-237.
90. Tada K, Roy Chowdhury N, Prasad VR, Kim B-H, Kalapudi M, Fox IJ, Duijvandijk P, Bosma PJ, and Roy Chowdhury J (1998) Long-term amelioration of bilirubin glucuronidation defect in Gunn rats by transplanting genetically modified immortalized autologous hepatocytes. Cell Transplant 7:607-616.
91. Takahashi M, Ilan Y, Roy Chowdhury N, Guida J, Horwitz MS, and Roy Chowdhury J (1996) Long-term correction of bilirubin UDP-glucuronosyltransferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period. J Biol Chem 271: 26536-26542.
92. Thummala NR, Ghosh SS, Lee SW, Reddy B, Davidson A, Horwitz MS, Roy Chowdhury J, and Roy Chowdhury N (2002) A non-immunogenic adenoviral vector, coexpressing CTLA41g and bilirubin-uridinediphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome. Gene Ther 9:981-990.
93. Tukey RH and Strassburg CP (2000) Human UDP-glucuronosyltransferases: metabolism, expression and disease. Annu Rev Pharmacol Toxicol 40:581-616.
94. Turgeon D, Carrier JS, Levesque E, Beatty BG, Belanger A, and Hum DW (2000) Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. J Mol Biol 295:489-504.
95. Ullrich D, Sieg A, Blume R, Bock KW, Schroter W, and Bircher J (1987) Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilbert's syndrome. Eur J Clin Investig 17:237-240.
96. Vienneau DS, DeBoni U, and Wells PG (1995) Potential genoprotective role for UDP-glucuronosyltransferases (UGTs) in chemical carcinogenesis: initiation of micronuclei by benzo[a]pyrene and benzo[e]pyrene in UGT-deficient cultured rat skin fibroblasts. Cancer Res 55:1045-1051.
97. Villeneuve L, Girard H, Fortier LC, and Guillemette C (2003) Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs. J Pharmacol Exp Ther 307:117-128.
98. Vogel A, Kneip S, Barut A, Ehmer U, Tukey RH, Manns MP, and Strassburg CP (2001) Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology 121:1136-1144.
99. Wells PG, Kim PM, Nicol CJ, Parman T, and Winn LM (1997) Chapter 17: Reactive intermediates, in Handbook of Experimental Pharmacology, Part I: Drug Toxicity in Embryonic Development (Kavlock RJ and Daston GP eds.), vol 124, pp 453-518, Springer-Verlag, Heidelberg.
100. Wells PG, Obilo FC, and de Morais SMF (1989) Benzo(a)pyrene embryopathy in rats genetically deficient in bilirubin UDP-glucuronyl transferase. FASEB J 3:A1025.
101. Wells PG and Winn LM (1996) Biochemical toxicology of chemical teratogenesis. Crit Rev Biochem Mol Biol 31:1-40.
102. Woolley AT, Guillemette C, Cheung CL, Housman DE, and Lieber CM (2000) Direct haplotyping of kilobase-size DNA using carbon nanotube probes. Nat Biotechnol 18:760-763.
103. Zheng Z, Park JY, Guillemette C, Schantz SP, and Lazarus P (2001) Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J Natl Cancer Inst 93:1411-1418.